tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jay Olson, 327 are a BUY (92.9%), 24 are a HOLD (6.82%), 1 are a SELL (0.28%).
Analyst Jay Olson, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 44.7% that have a potential upside of 38.16% achieved within 157 days.
Jay Olson’s has documented 769 price targets and ratings displayed on 46 stocks. The coverage is on Healthcare, Industrials, Financial Services sectors.
Most recent stock forecast was given on PRTA, Prothena plc at 27-May-2025.
Analyst best performing recommendations are on NKTR (NEKTAR THERAPEUTICS).
The best stock recommendation documented was for NKTR (NEKTAR THERAPEUTICS) at 11/7/2019. The price target of $20 was fulfilled within 1 day with a profit of $1.3 (6.95%) receiving and performance score of 69.52.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$30
$7.29 (32.10%)
$25
21 days ago
(06-Jun-2025)
5/9 (55.56%)
$8.02 (36.49%)
26
Hold
$23
$0.29 (1.28%)
$22
22 days ago
(05-Jun-2025)
7/9 (77.78%)
$1.66 (7.78%)
294
Hold
$35
$12.29 (54.12%)
$23
1 months 6 days ago
(21-May-2025)
0/4 (0%)
$13.15 (60.18%)
Hold
$24
$1.29 (5.68%)
$20
1 months 7 days ago
(20-May-2025)
17/22 (77.27%)
$2.31 (10.65%)
166
Buy
$31
$8.29 (36.50%)
$28
1 months 8 days ago
(19-May-2025)
0/4 (0%)
$9.01 (40.97%)
Which stock is Jay Olson is most bullish on?
Which stock is Jay Olson is most reserved on?
What Year was the first public recommendation made by Jay Olson?
